Br J Ophthalmol 1997;81:46-53 ( January )

Usher syndrome in the city of Birminghamprevalence and clinical classification

C I Hope,^a S Bundey,^b D Proops,^c A R Fielder^a

^a Department of Ophthalmology, University of Birmingham, Birmingham and Midland Eye Hospital, Birmingham , ^b Clinical Genetics Unit, University of Birmingham , ^c Ear Nose and Throat Department, Queen Elizabeth Hospital, Birmingham

Correspondence to: C I Hope, Department of Surgery (Ophthalmic section), School of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand.

Accepted for publication 14 October 1996

AIMSTo estimate the prevalence of Usher syndrome in the city of Birmingham, and to establish a database of patients who have been classified into different clinical subtypes essential for future gene mutation analysis.
METHODSSymptomatic cases of Usher syndrome (US) resident in the city of Birmingham in June 1994 were ascertained through multiple sources. Ophthalmic and audiological reassessment together with examination of medical records and patient questionnaires allowed classification of three subtypes, US 1, US 2, and US 3. In addition, family pedigrees were examined and blood was taken from index patients for DNA extraction.
RESULTSIn the population aged over 15 years the prevalence was 6.2 per 100 000 population for all US subtypes. The prevalence for US 1 and US 2 was 5.3 per 100 000 population. This is greater than previously reported. In the age group 30-49 years the prevalence approached 1 in 10 000. Clinical classification found 33% US 1, 47% US 2, and 20% US 3.
CONCLUSIONThis higher prevalence rate and greater frequency of US 2 and US 3 may reflect a more complete ascertainment.

---

© 1997 by British Journal of Ophthalmology
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Jacobson, S. G., Cideciyan, A. V., Aleman, T. S., Sumaroka, A., Roman, A. J., Gardner, L. M., Prosser, H. M., Mishra, M., Bech-Hansen, N. T., Herrera, W., Schwartz, S. B., Liu, X.-Z., Kimberling, W. J., Steel, K. P., Williams, D. S. (2008). Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Hum Mol Genet 17: 2405-2415 [Abstract] [Full Text]  
• Herrera, W., Aleman, T. S., Cideciyan, A. V., Roman, A. J., Banin, E., Ben-Yosef, T., Gardner, L. M., Sumaroka, A., Windsor, E. A. M., Schwartz, S. B., Stone, E. M., Liu, X.-Z., Kimberling, W. J., Jacobson, S. G. (2008). Retinal Disease in Usher Syndrome III Caused by Mutations in the Clarin-1 Gene. IOVS 49: 2651-2660 [Abstract] [Full Text]  
• Jaijo, T, Aller, E, Beneyto, M, Najera, C, Graziano, C, Turchetti, D, Seri, M, Ayuso, C, Baiget, M, Moreno, F, Morera, C, Perez-Garrigues, H, Millan, J M (2007). MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J. Med. Genet. 44: e71-e71 [Full Text]  
• Schwartz, S. B., Aleman, T. S., Cideciyan, A. V., Windsor, E. A. M., Sumaroka, A., Roman, A. J., Rane, T., Smilko, E. E., Bennett, J., Stone, E. M., Kimberling, W. J., Liu, X.-Z., Jacobson, S. G. (2005). Disease Expression in Usher Syndrome Caused by VLGR1 Gene Mutation (USH2C) and Comparison with USH2A Phenotype. IOVS 46: 734-743 [Abstract] [Full Text]  
• Hmani-Aifa, M, Arab, S B., Kharrat, K, Orten, D J, Boulila-Elgaied, A, Drira, M, Hachicha, S, Kimberling, W J, Ayadi, H (2002). Distinctive audiometric features between USH2A and USH2B subtypes of Usher syndrome. J. Med. Genet. 39: 281-283 [Full Text]